US Stock MarketDetailed Quotes

NLSP NLS Pharmaceutics

Watchlist
  • 5.2000
  • +0.2000+4.00%
Close Sep 27 16:00 ET
  • 5.0000
  • -0.2000-3.85%
Post 20:01 ET
6.09MMarket Cap-10P/E (TTM)

NLS Pharmaceutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

NLS Pharmaceutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2023/H10.000 / 0.000--
--2022/H20.000 / 0.000--
--2022/H10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2023/H10.000 / 0.000--
--2022/H20.000 / 0.000--
--2022/H10.000 / 0.000--
--------
--------

Unlock Free Earnings Estimates

NLS Pharmaceutics Earnings Reports

  • 6-K: Report of foreign private issuer (related to financial reporting)

    Sep 25 08:15 ET

  • 6-K: Report of foreign private issuer (related to financial reporting)

    Aug 26 16:42 ET

  • 6-K: Report of foreign private issuer (related to financial reporting)

    Aug 15 16:09 ET

  • 6-K: Report of foreign private issuer (related to financial reporting)

    Jul 1 08:13 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 23, 2024

    Hold

    • Buy

      0.00%

    • Hold

      100.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data